Melbourne, Australia, 22 October 2013: Neuren Pharmaceuticals (ASX: NEU) announced today that it has completed a placement of new shares to professional and sophisticated investors at 11.5 cents per share, providing additional capital of $21.5 million. The placement was heavily over-subscribed, an indication of the strong support from international and domestic institutional investors. Neuren also intends to offer a Share Purchase Plan at 11.5 cents per share, capped at $3 million, to shareholders registered at 7pm AEST on 18 October 2013.
announcement
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.99 |
Change
-0.570(3.91%) |
Mkt cap ! $1.806B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $4.568M | 322.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1519 | $13.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.00 | 955 | 12 |
View Market Depth
| Last trade - 15.58pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |